Generated by AI
Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for serious diseases. Bristol-Myers Squibb Company focuses on major therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and neuroscience, serving patients with complex and often chronic conditions. Its portfolio includes small-molecule drugs, biologics, and cell therapies, reflecting a broad approach to advanced treatment design and delivery. The company supports healthcare systems through research-driven products used in hospitals, specialty clinics, and outpatient care settings around the world. Bristol-Myers Squibb Company plays an important role in the pharmaceutical market by providing therapies aimed at difficult-to-treat illnesses and by maintaining a diversified pipeline and product mix across multiple disease categories.
WebsiteRoute 206 & Province Line Road
Princeton, NJ, 08543
United States
The latest articles about BMY.
Bristol Myers Squibb says KarXT cuts Alzheimer’s psychosis scores 12.0 points at 12 weeks; preliminary 52-week data show a 5.1-point drop.
Summary of Nov 17's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Summary of Aug 2's posts. Generated by AI.
Summary of Oct 29's posts. Generated by AI.
Investors talking about BMY also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.